We have reported before that during chronic phase of HIV-1 infection in humanized mice, blockade of IFN-I signaling using a mAb targeting to IFN-I receptor (IFNAR) reduces the level of T cell activation, reverses T cell exhaustion, and improves HIV-specific CD8+ T cells (29). This evidence concerns the gene CD8A and HIV-1 infection.